Synthesis, docking, pharmacokinetic prediction, and acetylcholinesterase inhibitory evaluation of N-(2-(piperidine-1-yl)ethyl)benzamide derivatives as potential anti-Alzheimer agents
Background and purpose: Alzheimer’s disease is the most common form of dementia and the sixth most common cause of death in the US according to the Alzheimer’s Association. As regards, to date, no effective treatments are available because of the multifactorial nature of the disease, therefore, a la...
Saved in:
Main Authors: | Ahmad Mohammadi-Farani, Farzaneh Moradi, Amin Hosseini, Alireza Aliabadi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Research in Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/RPS.RPS_257_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Crystal structure and Hirshfeld surface analysis of N-(4-nitrophenyl)-2-(piperidin-1-yl)acetamide (lidocaine analogue)
by: Imane Maimoune, et al.
Published: (2025-01-01) -
Molecular Docking Study of Caffeic Acid as Acetylcholinesterase Inhibitor
by: Stephanus Satria Wira Waskitha, et al.
Published: (2023-12-01) -
Synthesis and crystal structure of piperidinyl propanenitrile towards the preparation of piperidine based bioactive films for drug delivery applications
by: Reham A. Mohamed-Ezzat, et al.
Published: (2025-01-01) -
Virtual Screening, Toxicity Evaluation and Pharmacokinetics of Erythrina Alkaloids as Acetylcholinesterase Inhibitor Candidates from Natural Products
by: Permana A, et al.
Published: (2025-02-01) -
Thiamine and Thiamine Pyrophosphate as Non-Competitive Inhibitors of Acetylcholinesterase—Experimental and Theoretical Investigations
by: Łukasz Szeleszczuk, et al.
Published: (2025-01-01)